Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
11/2007
11/14/2007EP0952843B1 Pharmaceutical formulations for sustained drug delivery
11/14/2007EP0866654B1 Method for treating hepatitis virus infection
11/14/2007EP0756628B1 Morphogenic protein-specific cell surface receptors and uses therefor
11/14/2007EP0641218B2 Use of angiotensin antagonist (at1) for reducing post myocardial infarct mobidity and mortality
11/14/2007EP0587858B2 Protein formulation comprising growth hormone
11/14/2007CN101072875A Novel cancer antigen peptide and the use thereof
11/14/2007CN101072874A Aptamer regulated nucleic acids and uses thereof
11/14/2007CN101072579A Stimulation of proliferation of pluripotential stem cells through administration of pregnancy associated compounds
11/14/2007CN101072578A Combination cancer immunotherapy with co-stimulatory molecules
11/14/2007CN101072577A Analogs of shk toxin and their uses in selective inhibition of kv1.3 potassium channels
11/14/2007CN101072576A Methods of inhibiting cell death or inflammation in a mammal
11/14/2007CN101072575A Hcv ns3-ns4a protease inhibition
11/14/2007CN101072572A Isolation of bone marrow fraction rich in connective tissue growth components and the use thereof to promote connective tissue formation
11/14/2007CN101072571A Compositions for treatment of ear infections
11/14/2007CN101070546A Human LPL gene mutation body of resisting atheroscleorsis
11/14/2007CN101070542A Intensified tubercle-resisting action of human interleukin 24
11/14/2007CN101070540A New dendritic cell co-stimulatory molecules
11/14/2007CN101070350A Intensified fusion protein NGR-LDP-AE formed by target peptide to CD13 and lidamycin
11/14/2007CN101070349A Fusion protein with function of selective killing endothelial cells in tumor neogenetic blood vessels and use thereof
11/14/2007CN101070344A G-csf receptor agonist antibodies and screening method therefor
11/14/2007CN101070343A Vascular endothelial cell growth factor variants and uses thereof
11/14/2007CN101070342A Balsm-pear-seed ribosome inactivated protein and its coding gene and use
11/14/2007CN101070341A Antibacterial peptide without mutagenic action
11/14/2007CN101070340A Hornet anti-bacterial peptide, its preparing method and use
11/14/2007CN101069742A Pancreatic kininogenase tablet and preparing method
11/14/2007CN101069741A Medical radiation-ray preventive spray agent
11/14/2007CN100348618C Process for producing hydroxyalkyl starch derivatives
11/14/2007CN100348615C Gene of restraining activation NF-kB and NFAT, and coded polypeptide
11/14/2007CN100348614C Idiosyncratic antigen protein, and antigen peptide of liver cancer orchis pellet
11/14/2007CN100348267C Purification of red blood cells by separation and infiltration
11/14/2007CN100348266C Peptide antagonists of zonulin and methods for use of the same
11/14/2007CN100348265C Controlled release composition and method of producing the same
11/13/2007US7294713 Antisense IAP oligonucleotides and uses thereof
11/13/2007US7294712 Nucleotide sequences coding for variable regions of β chains of human T lymphocyte receptors, corresponding peptide segments and the diagnostic and therapeutic uses
11/13/2007US7294710 High-affinity choline transporter
11/13/2007US7294708 Telomerase reverse transcriptase fragments and uses thereof
11/13/2007US7294706 Fibroblast growth factor polypeptide for identifying modulators for treatment of tumor neovascularization and diabetic retinopathy; wound healing agents; angiogenesis activator
11/13/2007US7294705 Anti-PRO3580 antibodies
11/13/2007US7294703 Vectors with DNA encoding pro polypeptides
11/13/2007US7294702 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/13/2007US7294700 Anti-PRO846 antibodies
11/13/2007US7294699 Factor vii or factor ix polypeptides; enhanced membrane binding; blood disorders; blood coagulation
11/13/2007US7294698 An isolated Archipelin polypeptide
11/13/2007US7294697 Short chain neurotoxin from sea snake-Lapemis hardwickii and genes encoding the neurotoxin
11/13/2007US7294693 Pro4428 Polypeptides
11/13/2007US7294692 Vectors with DNA encoding pro polypeptides
11/13/2007US7294689 From Vibrio cholerae phage; cadherins; immunogens; drug screening; for treatment of autoimmune and gastrointestinal diseases, food allergies, and Celiac disease; vaccines; antibodies
11/13/2007US7294687 For alleviating symptoms of systemic lupus erythematosus (SLE) in a human subject
11/13/2007US7294652 Autoimmune conditions and NADPH oxidase defects
11/13/2007US7294622 Lactams and uses thereof
11/13/2007US7294617 Method for nonsurgical treatment of the intervertebral disc and kit therefor
11/13/2007US7294616 Capreomycin derivatives and their use as antibacterials
11/13/2007US7294615 Compounds that associate on the intermolecular level and aggregate bodies that contain them
11/13/2007US7294613 Beta-defensins
11/13/2007US7294510 Propagating neuronal stem cells in nutrient broth comprising hedgehog, fibroblast growth factor and noggin proteins; for treatment of amyotrophic lateral sclerosis, huntington's chorea and alzheimer's disease; tissue engineering
11/13/2007US7294504 For suppressing the expression of a gene targets and for degrading a target RNA using DNA as a vehicle
11/13/2007US7294497 Compositions and methods for enzymatic detachment of bacterial and fungal biofilms
11/13/2007US7294496 Cloned human lysophospholipase
11/13/2007US7294495 PR03580 polypeptides
11/13/2007US7294477 Allergen and treatment
11/13/2007US7294475 Gene and use thereof
11/13/2007US7294473 Methods of identifying substances that interact with JTT-1 protein
11/13/2007US7294472 Method for identifying modulators of G protein coupled receptor signaling
11/13/2007US7294459 Cell regulatory genes, encoded products, and uses related thereto
11/13/2007US7294455 Fixed-dried platelets cross-linked to protein
11/13/2007US7294352 Matrix protein composition for treating inflammation
11/13/2007US7294339 Method for treating allodynia by peripheral administration of a neurotoxin
11/13/2007US7294334 Methods and compositions to treat myocardial conditions
11/13/2007US7294333 Modifying the electrophysiological function of the heart and treating atrial fibrillation or ventricular tachycardia by implanting allogeneic or autogeneic fibroblasts expressing an exogenous voltage-gated or inward-rectifier potassium ion channel polypeptide into the heart
11/13/2007US7294332 Combination therapy (temozolomide and α-IFN) for advanced cancer
11/13/2007US7294331 Methods of using flt3-ligand in hematopoietic cell transplantation
11/13/2007CA2333469C Myotilin, an actin-organizing protein
11/13/2007CA2318398C Novel peptides having biological activity
11/13/2007CA2292965C Pyrrolidine derivative hair growth compositions and uses
11/13/2007CA2285574C Method and composition for treating sleep apnea
11/13/2007CA2283637C Upar mimicking peptide
11/13/2007CA2251008C Macromolecular complexes for drug delivery
11/13/2007CA2241171C Product derived from milk substantially free of beta casein from non-human mammals and relative use
11/13/2007CA2226142C Purification of dalbaheptide antibiotics by isoelectric focusing
11/13/2007CA2222680C Endoparasiticidal agents
11/13/2007CA2006813C Purified ciliary neurotrophic factor
11/09/2007CA2589295A1 Characterization of c19orf10, a novel synovial protein
11/08/2007WO2007127965A1 Treating glaucoma, cardiovascular diseases, and renal diseases
11/08/2007WO2007127935A1 Dephosphorylation of hdac7 by myosin phosphatase
11/08/2007WO2007127841A2 Compositions and methods of preparation thereof
11/08/2007WO2007127839A2 Compositions and methods for convection enhanced delivery of high molecular weight neurotherapeutics
11/08/2007WO2007127837A2 Microspheroidal-controlled release of biomolecules
11/08/2007WO2007127813A2 Modulation of signal transduction by site specific ultrasound agent delivery of transmembrane acting compounds
11/08/2007WO2007127803A2 Administration of growth factors for the treatment of cns disorders
11/08/2007WO2007127667A1 Augmentation of titer for vaccination in animals
11/08/2007WO2007127457A2 Ghrelin/growth hormone releasing peptide/growth hormone secretatogue receptor antagonists and uses thereof
11/08/2007WO2007127439A2 Compositions comprising fusogenic proteins or polypeptides derived from prosaposin for application in transmembrane drug delivery systems
11/08/2007WO2007127231A2 Magnetic resonance-detectable, ultrasound-detectable and/or radiopaque microcapsules and uses thereof
11/08/2007WO2007127207A2 Fixed combination dosage forms for the treatment of migraine
11/08/2007WO2007127198A2 Protein crosslinkers, crosslinking methods and applications thereof
11/08/2007WO2007127173A2 Therapeutic compounds
11/08/2007WO2007127145A2 Methods and compositions for treatment of cardiac arrhythmia in non-human animals
11/08/2007WO2007126950A1 Parenteral low dose type 1 interferons for bladder cancer
11/08/2007WO2007126849A1 Cyclic hexadepsipeptides, processes for their production and their use as pharmaceuticals
11/08/2007WO2007126832A2 Pharmaceutical compositions for prevention of overdose or abuse